316
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Synergistic/additive interaction of valproic acid with bortezomib on proliferation and apoptosis of acute myeloid leukemia cells

, , , , , , , & show all
Pages 2487-2495 | Received 20 Mar 2012, Accepted 23 May 2012, Published online: 18 Jun 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Muneera Al-Hussaini & John F DiPersio. (2014) Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic. Expert Review of Hematology 7:4, pages 439-464.
Read now
Denise Niewerth, Ilse Dingjan, Jacqueline Cloos, Gerrit Jansen & Gertjan Kaspers. (2013) Proteasome inhibitors in acute leukemia. Expert Review of Anticancer Therapy 13:3, pages 327-337.
Read now

Articles from other publishers (16)

Øystein Bruserud, Galina Tsykunova, Maria Hernandez-Valladares, Hakon Reikvam & Tor Henrik Anderson Tvedt. (2021) Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation. Pharmaceuticals 14:5, pages 423.
Crossref
San José-Enériz, Gimenez-Camino, Agirre & Prosper. (2019) HDAC Inhibitors in Acute Myeloid Leukemia. Cancers 11:11, pages 1794.
Crossref
Yun Liu, Wen-Jing Huang, Min-Ting Lin, Jia-Jun Li & Jian-Ye Zhang. 2019. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy 207 228 .
Danian Nie, Kezhi Huang, Songmei Yin, Yiqing Li, Shuangfeng Xie, Liping Ma, Xiuju Wang, Yudan Wu, Jie Xiao, Jieyu Wang, Wenjuan Yang & Hongyun Liu. (2018) KPT-330 inhibition of chromosome region maintenance 1 is cytotoxic and sensitizes chronic myeloid leukemia to Imatinib. Cell Death Discovery 4:1.
Crossref
Subbroto Saha, Yingfu Yin, Kyeongseok Kim, Gwang-Mo Yang, Ahmed Dayem, Hye Choi & Ssang-Goo Cho. (2017) Valproic Acid Induces Endocytosis-Mediated Doxorubicin Internalization and Shows Synergistic Cytotoxic Effects in Hepatocellular Carcinoma Cells. International Journal of Molecular Sciences 18:5, pages 1048.
Crossref
Alice Bertaina, Luciana Vinti, Luisa Strocchio, Stefania Gaspari, Roberta Caruso, Mattia Algeri, Valentina Coletti, Carmelo Gurnari, Mariateresa Romano, Maria Giuseppina Cefalo, Katia Girardi, Valentina Trevisan, Valentina Bertaina, Pietro Merli & Franco Locatelli. (2017) The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood. British Journal of Haematology 176:4, pages 629-636.
Crossref
C M Csizmar, D-H Kim & Z Sachs. (2016) The role of the proteasome in AML. Blood Cancer Journal 6:12, pages e503-e503.
Crossref
Maryam Moradi Binabaj, Seyed Ahmad Hosseini, Alireza Khoshbin Khoshnazar & Jahanbakhsh Asadi. (2015) The Simultaneous Effect of Valproic Acid and Gamma Radiation on Telomerase Activity and Bax and Bcl-2 Protein Levels in MCF-7 Breast Cancer Cell Line. Jundishapur Journal of Natural Pharmaceutical Products 10:3.
Crossref
Leila Haery, Ryan C. Thompson & Thomas D. Gilmore. (2015) Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy. Genes & Cancer 6:5-6, pages 184-213.
Crossref
QITIAN MU, QIULING MA, SHASHA LU, TING ZHANG, MENGXIA YU, XIN HUANG, JIAN CHEN & JIE JIN. (2014) 10058-F4, a c-Myc inhibitor, markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells. Oncology Letters 8:3, pages 1355-1359.
Crossref
Mohamed-Salah Abaza, Abdul-Majeed Bahman & Raja'a Al-Attiyah. (2014) Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: Underlying molecular mechanisms. International Journal of Molecular Medicine.
Crossref
Jacqueline Cloos, Denise Niewerth & Gerrit Jansen. 2014. Resistance to Proteasome Inhibitors in Cancer. Resistance to Proteasome Inhibitors in Cancer 181 204 .
Hanne Fredly, Bjørn Tore Gjertsen & Øystein Bruserud. (2013) Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents. Clinical Epigenetics 5:1.
Crossref
HUI CAO, YIZHI CHENG, LIANGSHUN YOU, JIEJING QIAN & WENBIN QIAN. (2013) Homoharringtonine and SAHA synergistically enhance apoptosis in human acute myeloid leukemia cells through upregulation of TRAIL and death receptors. Molecular Medicine Reports 7:6, pages 1838-1844.
Crossref
Xiaofei Li, Yanshuang Zhu, Huabin He, Lianqing Lou, Weiwei Ye, Yongxin Chen & Jinghe Wang. (2013) Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells. Biochemical and Biophysical Research Communications 436:2, pages 259-264.
Crossref
Xiao-Li Du & Qi Chen. (2013) Recent Advancements of Bortezomib in Acute Lymphocytic Leukemia Treatment. Acta Haematologica 129:4, pages 207-214.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.